Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND)

Area of Science:

• Genetics
• Neuroscience
• Developmental Biology

Background:

• MBD5-associated neurodevelopmental disorder (MAND) is a spectrum of conditions impacting neurodevelopment, cognition, and behavior.
• These disorders include 2q23.1 deletion syndrome, 2q23.1 duplication syndrome, and mutations in the MBD5 gene.
• All MAND conditions involve impaired function of the methyl-binding domain 5 (MBD5) protein.

Purpose of the Study:

• To provide a comprehensive clinical and molecular review of 2q23.1 deletion syndrome.
• To summarize current diagnostic, genetic counseling, and management strategies for 2q23.1 deletion syndrome.
• To discuss the molecular and functional significance of MBD5 and related disorders.

Main Methods:

• Literature review and synthesis of existing clinical and molecular data.
• Analysis of diagnostic approaches and genetic counseling principles.
• Summary of current management guidelines and therapeutic interventions.

Main Results:

• 2q23.1 deletion syndrome presents with a consistent set of neurodevelopmental, cognitive, and behavioral challenges.
• The review details the genetic basis, clinical manifestations, and diagnostic criteria for this syndrome.
• The functional role of MBD5 in neurodevelopment is explored, alongside MBD5 variants and 2q23.1 duplication syndrome.

Conclusions:

• 2q23.1 deletion syndrome is a significant component of MAND, requiring tailored clinical and molecular understanding.
• Effective diagnosis, genetic counseling, and management are crucial for individuals with 2q23.1 deletion syndrome.
• Further research into MBD5 function and related syndromes will enhance therapeutic strategies for MAND.